Full Press Release Details
BELGRADE, MT, March 2, 2015 -- Bacterin International
Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone graft material, today announced that it will
release its financial results for the period and full year ended December 31, 2014, on March 17, 2015 at the close of the financial
An accompanying conference call will be hosted by Dan Goldberger,
Chief Executive Officer, and John Gandolfo, Chief Financial Officer, to discuss the results. The call will be held at 10:00 a.m.
ET, on March 18, 2015. Please refer to the information below for conference call dial-in information and webcast registration.
Conference date: March 18, 2015, 10:00 AM ET
Conference dial-in: 877-269-7756
International dial-in: 201-689-7817
Conference Call Name: Bacterin's Fourth Quarter 2014
Webcast Registration: Click Here
Following the live call, a replay will be available on the
Company's website, www.bacterin.com, under "Investor Info".
About Bacterin International Holdings
Bacterin International Holdings, Inc. (NYSE MKT: BONE) develops,
manufactures and markets biologics products to domestic and international markets. These products are used in a variety of applications
including enhancing fusion in spine surgery, relief of back pain, promotion of bone growth in foot and ankle surgery, promotion
of cranial healing following neurosurgery and subchondral repair in knee and other joint surgeries.
For further information, please visit www.bacterin.com.
Important Cautions Regarding Forward-looking Statements
This news release contains certain disclosures that may be deemed
forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to significant
risks and uncertainties. Forward-looking statements include statements that are predictive in nature, that depend upon or refer
to future events or conditions, or that include words such as "continue," "efforts," "expects," "anticipates,"
"intends," "plans," "believes," "estimates," "projects," "forecasts,"
"strategy," "will," "goal," "target," "prospects," "potential," "optimistic,"
"confident," "likely," "probable" or similar expressions or the negative thereof. Statements of historical
fact also may be deemed to be forward-looking statements. We caution that these statements by their nature involve risks and uncertainties,
and actual results may differ materially depending on a variety of important factors, including, among others: the Company's ability
to meet its existing and anticipated contractual obligations, including financial covenant and other obligations contained in the
Company's secured lending facility; the Company's ability to manage cash flow and achieve profitability; the Company's ability
to remain listed on the NYSE MKT; the Company's ability to develop, market, sell and distribute desirable applications, products
and services and to protect its intellectual property; the ability of the Company's sales force to achieve expected results; the
ability of the Company's customers to pay and the timeliness of such payments; the Company's ability to obtain financing as and
when needed; changes in consumer demands and preferences; the Company's ability to attract and retain management and employees
with appropriate skills and expertise; the Company's ability to successfully conclude government investigations; the impact of
changes in market, legal and regulatory conditions and in the applicable business environment, including actions of competitors;
and other factors. Additional risk factors are listed in the Company's Annual Report on Form 10-K and Quarterly Reports on Form
10-Q under the heading "Risk Factors." The Company undertakes no obligation to release publicly any revisions to any
forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated
events, except as required by law.